Archives: Agenda

• Ensuring your trial is both cost-conscious and efficient without compromising on quality
• Techniques, processes and technology to improve forecasting and budgeting
• Avoiding common mistakes to keep your clinical trial budget on track

As with all industries, artificial intelligence is generating significant buzz in the clinical research space. But where does it offer meaningful impact today, and where is there still work to be done? In this session, we’ll explore the practical realities of applying AI tools within the context of electronic clinical outcomes assessment data, from operational efficiencies like study setup and translation to the future promise of patient-facing applications. Join us for an honest look at what’s achievable now, what’s emerging, and how to think strategically about this fast-moving future.

• Defining a start-up plan based on key study objectives
• Using a data driven approach for effective start-up planning, including data from regulatory intelligence, site intelligence, and KPIs to support start-up planning
• How effective start-up execution drives a successful trial

• Exposing the inefficiencies of current vendor qualification practices and challenging the industry to adopt a proven process innovation that will help sponsors onboard vendors more quickly leading to a real reduction in clinical trial start-up times
• Learn how embracing innovation, and adopting a risk-based data-driven approach to vendor management can help organizations strength their compliance practices in a heavily regulated industry
• Uncover the advantages of a centralized approach to vendor qualification that provides unique benefits to both sponsors and vendors across the globe

• An overview of common challenges and how to overcome these
• Securing initial funding: navigating opportunities available to raise capital
• Overcoming early stage hurdles
• Building strategic partnerships to support your biotech

• Evaluating CRO capabilities and experience relevant to your specific therapeutic area and development stage
• Balancing cost, quality and timelines within tight budget constraints
• Negotiating contracts with flexibility to protect your biotech’s goals

• Weighing up pros and cons of different outsourcing models: which is best for your trial?
• When is mixing and matching better than fully outsourcing or keeping trials fully in house?
• Developing an outsourcing strategy as a small to medium sized biotech with limited resources
• Why is FSP becoming a popular choice among sponsor companies and how can this support meeting trial timelines?

• How early engagement can improve outcomes
• Unlocking the value of your pipeline
• Purposeful partnering with bespoke solutions